Company profile for Bantam Pharmaceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Bantam Pharmaceutical is a drug discovery company harnessing the power of mitochondrial dynamics to address unmet needs in oncology. Using its unique expertise in mitochondrial dynamics, Bantam is developing novel, first-in-class small molecule oral therapeutics for difficult-to-treat hematological and solid tumors. Bantam is currently pursuing an IND application for Its lead candidate, BTM-3566, in B-cell malignancies. At Ban...
Bantam Pharmaceutical is a drug discovery company harnessing the power of mitochondrial dynamics to address unmet needs in oncology. Using its unique expertise in mitochondrial dynamics, Bantam is developing novel, first-in-class small molecule oral therapeutics for difficult-to-treat hematological and solid tumors. Bantam is currently pursuing an IND application for Its lead candidate, BTM-3566, in B-cell malignancies. At Bantam Pharmaceutical, we are developing novel, first-in-class small molecule oral therapeutics for difficult-to-treat hematological and solid tumors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
9 Laboratory Drive, Suite 2251 PO Box: 110247 Durham, NC 27709
Telephone
Telephone
(646) 598-4823
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Natural Product Expo West

Natural Product Expo West

Not Confirmed

envelop Contact Supplier

Natural Product Expo West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/bantam-pharmaceutical-announces-first-patient-treated-in-btm-3566-phase-1-clinical-trial-at-princess-margaret-cancer-centre-in-toronto-302637647.html

PR NEWSWIRE
10 Dec 2025

https://www.prnewswire.com/news-releases/bantam-pharmaceutical-to-present-at-the-american-society-of-clinical-oncology-asco-2025-annual-meeting-302463773.html

PR NEWSWIRE
22 May 2025

https://www.prnewswire.com/news-releases/bantam-pharmaceutical-presents-new-preclinical-data-for-btm-3566-at-the-american-association-for-cancer-research-aacr-annual-meeting-2025-302438580.html

PR NEWSWIRE
25 Apr 2025

https://www.prnewswire.com/news-releases/bantam-pharmaceutical-accelerates-btm-3566-clinical-program-expanding-phase-1-trial-into-canada-302393938.html

PR NEWSWIRE
06 Mar 2025

https://www.prnewswire.com/news-releases/bantam-pharmaceutical-announces-activation-of-first-phase-1-clinical-trial-site-at-md-anderson-cancer-center-302381558.html

PR NEWSWIRE
20 Feb 2025

https://www.prnewswire.com/news-releases/bantam-pharmaceutical-to-present-at-biotech-showcase-2023-301716623.html

PR NEWSWIRE
09 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty